Evidence map›Paper›PMID 26924772›Full record

ReviewBiochimica et biophysica acta2016

Shutting down the pore: The search for small molecule inhibitors of the mitochondrial permeability transition.

Justina Šileikytė, Michael Forte

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Mitochondrial Permeability Transition in Mitochondrial Disorders.Oxidative medicine and cellular longevity · 2019
    Review
  10. Review
  11. X-ray structure of alisporivir in complex with cyclophilin A at 1.5 Å resolution.Acta crystallographica. Section F, Structural biology communications · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. A Mitocentric View of Alzheimer's Disease.Molecular neurobiology · 2017
    Review
  16. Absence of physiological CaSkeletal muscle · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Justina ŠileikytėDepartment of Biomedical Sciences, University of Padova, Padova I-35131, Italy.
Michael ForteVollum Institute, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: forte@ohsu.edu.
University of Padua · ITVollum Institute · US

Funding

Molecular Structure and Regulation of the Permeability Transition PoreR01GM069883 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI FORTE, MICHAEL A · 2004 to 2016
$3.3M
NIGMS NIH HHS R01 GM069883
6 · The paper itself

Abstract

The mitochondrial permeability transition pore (PTP) is now recognized as playing a key role in a wide variety of human diseases whose common pathology may be based in mitochondrial dysfunction. Recently, PTP assays have been adapted to high-throughput screening approaches to identify small molecules specifically inhibiting the PTP. Following extensive secondary chemistry, the most potent inhibitors of the PTP described to date have been developed. This review will provide an overview of each of these screening efforts, use of resulting compounds in animal models of PTP-based diseases, and problems that will require further study. This article is part of a Special Issue entitled 'EBEC 2016: 19th European Bioenergetics Conference, Riva del Garda, Italy, July 2-6, 2016', edited by Prof. Paolo Bernardi.

Indexed as

AnilidesBenzamidinesCyclosporineDrug DesignHigh-Throughput Screening AssaysIsoxazolesMitochondriaMitochondrial MembranesMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreOximesPeptides, CyclicQuinolinium CompoundsSecosteroidsStructure-Activity Relationship3,5-seco-4-norcholestan-5-one oxime-3-olalisporivirAnilidesBenzamidinesCyclosporineIsoxazolesJW47 compound(melle-4)cyclosporinMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreOximesPeptides, CyclicQuinolinium CompoundsSecosteroidsHigh-throughputInhibitorsMitochondriaPermeability transitionScreening

Identifiers

PMID26924772
PMCPMC4893955
OpenAlexW2282754507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.